Fei Sun
Impact in
- Pharmacology top 10%
- Fungal Biology and Applications
- Microbial Natural Products and Biosynthesis
Papers in
-
- Glycosylation and Glycoproteins Research 4
- CRISPR and Genetic Engineering 2
- Protein purification and stability 2
-
- Fungal Biology and Applications 7
- Co-authors
- Chongyang Liang (13 shared papers)Shuqin Zhang (8 shared papers)Zhiyi Liu (7 shared papers)Lixia Liu (2 shared papers)Hui Zhou (2 shared papers)Zhihui Ren (3 shared papers)Yao Li (2 shared papers)Yan Li (2 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)Immunopharmacology and Immunotoxicology (2 papers)Protein Expression and Purification (2 papers)PLoS ONE (2 papers)Inflammation Research (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Fei Sun
33 papers receiving 541 citations
Peers
Comparison fields: 5 of 107
- Pharmacology 124
- Complementary and alternative medicine 59
- Biomaterials 87
- Pharmacology 42
- Biotechnology 37
Countries citing papers authored by Fei Sun
This map shows the geographic impact of Fei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Sun more than expected).
Fields of papers citing papers by Fei Sun
This network shows the impact of papers produced by Fei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Sun. The network helps show where Fei Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 68 | |
| 2 | 2019 | 55 | |
| 3 | 2015 | 48 | |
| 4 | 2017 | 47 | |
| 5 | 2008 | 45 | |
| 6 | 2011 | 42 | |
| 7 | 2014 | 33 | |
| 8 | 2020 | 22 | |
| 9 | 2014 | 21 | |
| 10 | 2013 | 19 | |
| 11 | 2008 | 19 | |
| 12 | 2012 | 18 | |
| 13 | Ganoderma lucidum immunomodulatory protein(Lz-8) expressed in Pichia pastoris and the identification of immunocompetence. | 2009 | 12 |
| 14 | 2021 | 10 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 8 | |
| 17 | 2012 | 8 | |
| 18 | 2021 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2016 | 8 |
About Fei Sun
Fei Sun is a scholar working on Molecular Biology, Pharmacology, Oncology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 35 papers that have together received 549 indexed citations. Recurring topics across this work include Fungal Biology and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (4 papers), Nanoparticle-Based Drug Delivery (2 papers), CRISPR and Genetic Engineering (2 papers), Herbal Medicine Research Studies (2 papers), Protein purification and stability (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Pharmacology (124 citations), Complementary and alternative medicine (59 citations), Biomaterials (87 citations), Pharmacology (42 citations) and Biotechnology (37 citations). Fei Sun has collaborated with scholars based in China, United States and India. Frequent co-authors include Chongyang Liang, Shuqin Zhang, Zhiyi Liu, Lixia Liu, Hui Zhou, Zhihui Ren, Yao Li, Yan Li, Dacheng Wang and Gefu Chi. Their work appears in journals such as Frontiers in Pharmacology, Immunopharmacology and Immunotoxicology, Protein Expression and Purification, PLoS ONE and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.